Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (MRMD)
OTHER OTC:MRMD
Total Valuation
MariMed has a market cap or net worth of $30.48M. The enterprise value is $122.02M.
Market Cap$30.48M
Enterprise Value$122.02M
Share Statistics
MariMed has 395,073,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding395,073,640
Owned by Insiders10.75%
Owned by Institutions0.26%
Financial Efficiency
MariMed’s return on equity (ROE) is -0.98 and return on invested capital (ROIC) is -1.56%.
Return on Equity (ROE)-0.98
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-1.56%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee223.53K
Profits Per Employee-20.26K
Employee Count715
Asset Turnover0.79
Inventory Turnover2.79
Valuation Ratios
The current PE Ratio of MariMed is ―. MariMed’s PEG ratio is -0.15.
PE Ratio―
PS Ratio0.21
PB Ratio2.33
Price to Fair Value2.33
Price to FCF5.25
Price to Operating Cash Flow4.01
PEG Ratio-0.15
Income Statement
In the last 12 months, MariMed had revenue of 159.83M and earned -14.48M in profits. Earnings per share was -0.04.
Revenue159.83M
Gross Profit57.88M
Operating Income-2.33M
Pretax Income-10.86M
Net Income-14.48M
EBITDA-2.82M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was 7.70M and capital expenditures -1.41M, giving a free cash flow of 6.28M billion.
Operating Cash Flow7.70M
Free Cash Flow6.28M
Free Cash Flow per Share0.02
Dividends & Yields
MariMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-23.00%
50-Day Moving Average0.09
200-Day Moving Average0.10
Relative Strength Index (RSI)40.81
Average Volume (3m)1.40M
Important Dates
MariMed upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateMar 11, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
MariMed as a current ratio of 1.00, with Debt / Equity ratio of 679.70%
Current Ratio1.00
Quick Ratio0.38
Debt to Market Cap2.67
Net Debt to EBITDA9.94
Interest Coverage Ratio-0.31
Taxes
In the past 12 months, MariMed has paid 3.59M in taxes.
Income Tax3.59M
Effective Tax Rate-0.33
Enterprise Valuation
MariMed EV to EBITDA ratio is 13.68, with an EV/FCF ratio of 19.22.
EV to Sales0.79
EV to EBITDA13.68
EV to Free Cash Flow19.22
EV to Operating Cash Flow16.31
Balance Sheet
MariMed has $8.88M in cash and marketable securities with $85.36M in debt, giving a net cash position of -$76.48M billion.
Cash & Marketable Securities$8.88M
Total Debt$85.36M
Net Cash-$76.48M
Net Cash Per Share-$0.19
Tangible Book Value Per Share$0.06
Margins
Gross margin is 32.05%, with operating margin of -1.46%, and net profit margin of -9.06%.
Gross Margin32.05%
Operating Margin-1.46%
Pretax Margin-6.80%
Net Profit Margin-9.06%
EBITDA Margin5.74%
EBIT Margin-1.46%
Analyst Forecast
The average price target for MariMed is $0.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$0.25
Price Target Upside212.50% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-0.34%
EPS Growth Forecast-24.00%